New York BRANY power

Group wins more clinical studies for local institutions, with benefits beyond the Hudson

Written byEdward Winnick
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An alliance of clinical institutions in New York City has attracted clinical studies and research dollars to the numerous medical schools and hospitals in the city, according to the group's president. Opportunities are up, and start-up time is down. But the group has also benefited other research facilities around the country and now has more than 100 affiliates in 18 states.

In the late 1990s, officials at the New York Academy of Medicine had noticed that the number of clinical trials taking place in New York City had dropped from a decade earlier. Although there were many reasons for the decline, one of the main ones was that bureaucratic issues at academic institutions had delayed projects from starting and had discouraged sponsors from future collaborations. In response, the academy, along with five New York City–area institutions, formed the Biomedical Research Alliance of New York (BRANY) in 1998.

Since then, BRANY ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies